Introduction
Proper functioning of the nervous system requires connections between neurons and their targets. Undifferentiated cells have to expand cylindrical extensions with a growth cone at a distal tip in a process called neurite outgrowth. This process, for all neurons, can be seen as a three step event. First, the round shape of the cell is broken down and a filopodia-like extension is generated. Second, the extension elongates and it is transformed into a proper neurite. Finally, the neurite differentiates into an axon or a dendrite (reviewed in (da Silva and Dotti, 2002) ). Understanding how the neurite initiation-site forms and what discriminates it from the rest of the cell on the molecular level is a major challenge, not only because it is an important event during nervous system development but also because the establishment of subcellular domains with distinct molecular components and properties is a fundamental problem in cell biology. Another important question is how neurite elongation is controlled?
Genetic and biochemical approaches have been applied to identify and characterise single molecular components involved in neurite outgrowth. For example, a wealth of evidence in recent years suggests that actin and microtubules dynamics and membrane traffic play a central role in neurite outgrowth initiation and neurite elongation. One of the first events that happens during initiation of neurite outgrowth is actin cytoskeleton rearrangement, mediated by a plethora of actin remodelling proteins, in particular by the Rho family of GTPases and their associated regulators (reviewed in (da Silva and Dotti, 2002) ). Cdc42, RhoA and Rac1 are the best characterised Rho GTPases with a role in neurite outgrowth, and, although results differ from one neuronal model to the other, it is believed that Cdc42 and Rac1 promote neurite outgrowth while RhoA suppresses it (reviewed in (Gallo and Letourneau, 1998; da Silva and Dotti, 2002) ). Microtubules are equally essential for neurite outgrowth (Solomon, 1980; Rochlin et al., 1996) , and thus proteins which regulate microtubule dynamics are also potential regulators of neurite outgrowth (for reviews see (Dehmelt and Halpain, 2004; Grenningloh et al., 2004) . It has been proposed that microtubules have a role in neurite elongation (Rochlin et al., 1996) , however, microtubules have also been observed to enter the lamellipodia of morphologically undifferentiated neuroblastoma cells prior to neurite initiation suggesting they might have a role in neurite initiation as well (Dehmelt et al., 2003) .
Membrane traffic regulators such as SNAREs (Osen-Sand et al., 1993; Shirasu et al., 2000) , Rab proteins (Huber et al., 1995) and the exocyst complex (Vega and Hsu, 2001 ) have also been implicated in neurite outgrowth regulation. Such role of membrane traffic regulation becomes apparent considering that the growth of neurite processes from the cell body involves a massive increase in cell surface area (Futerman and Banker, 1996) . Regulation of neurite outgrowth is an important aspect not only for proper development of the nervous system but also for tissue regeneration after nerve injury and the treatment of neuropathological conditions (Jones et al., 2001 ).
Despite this wealth of available information on neurite outgrowth regulation it is well recognised in the field that more systematic approaches to identify new molecules involved are needed in order to obtain a more complete molecular description underlying this complex process (Grant, 2003) . Recently, a large-scale RNAi screen was used to identify genes involved in synapse structure and function (Sieburth et al., 2005) underlining the importance of such systematic approaches.
Here we describe the establishment and application of a microscope based screening approach to identify novel human proteins involved in neurite outgrowth.
The rational of our experimental strategy is shown in Figure 1 . Candidate proteins that are expressed in nervous tissue are preselected based on their subcellular localisation in Vero cells. Cells are transfected with chosen GFP-tagged ORFs and subsequently their localisation during neurite outgrowth and the effect of their overexpression on this process are investigated. The assumption of this is that those proteins localising to the site of neurite outgrowth and/or interfere with the process due to their over-expression are highly likely to be involved in this process. This identified 21 proteins that effected neurite outgrowth when over-expressed in cells. Time-lapse microscopy was then used to determine when these effector proteins affect neurite outgrowth. Finally, effectors are co-expressed with known neurite outgrowth regulators to reveal possible functional interactions.
Materials and Methods

Materials
GFP-tagged ORFs were generated and prepared as previously described (Simpson et al., 2000) . Full length cDNA for SNAP-25, VAMP-2 and RhoA were obtained from the RZPD in pCMV-SPORT6, pOTB7 and pDNR-LIB vectors, respectively and subcloned into the pEGFP-C2 vector at the EcoRI/BamHI sites.
EB1-GFP and EB3-GFP constructs are kind gifts from Niels Galjart (Erasmus University, Rotterdam, Netherlands), AnnexinA4-YFP and CaMKIIβ-GFP are kind gifts from Carsten Schultz (European Molecular Biology Laboratory, Heidelberg, Germany), Cdc42-GFP is kind gifts from Panos Kouklis (University of Ioannina, Grece). Inhibitors used are: ROCK inhibitor Y-27632 (Calbiochem), Gsk3β inhibitor CHIR99021 (kind gift from Rudi Marquez and Natalia Shpiro from University of Dundee, UK).
Cell Culture
PC12 cells (clone 6-15), a kind gift from Dionisio Martin Zanca (University of Salamanca, Spain) were grown in medium containing DMEM (GibcoBRL) supplemented with 5% foetal calf serum (PAA), 10% heat inactivated horse serum (GibcoBRL), 1% L-glutamine (GibcoBRL) and 1% penicillin/streptomycin (GibcoBRL) at 37 o C in 5% CO 2 . To facilitate otherwise poorly attaching PC12 cells all plasticware used was coated with type I collagen from rat tail (Sigma).
Time-lapse microscopy
PC12 cells were plated in 35mm glass bottom dishes (Willco) which were previously coated with poly-L-lysine (Sigma) to facilitate cell attachment to the glass.
They were incubated at 37 o C in 5% CO 2 for 16 hours, after which they where transfected with 0.5 μg of appropriate cDNA and 1.5 μl of Lipofectamine2000 (Invitrogen) according to manufacturer's protocol. After 4 hours the transfection medium was replaced with fresh medium and the cells were left for another 16 hours.
After this the medium was replaced with CO 2 dependent imaging medium (2.2 g/l . Each gene's "fold change" value represents the mean +/-S.D. of three independent experiments.
Neurite outgrowth assay
Cells were plated on poly-L-lysine coated glass coverslips in 12 well plates and left for 16 hours at 37 o C in 5% CO 2 . Next, they were transfected with 0.5 μg of appropriate cDNA and 1.5 μl of Lipofectamine2000 (Invitrogen) according to manufacturer's protocol. Two wells were transfected with the same cDNA of interest and subsequently one was treated with NGF and the other not. Two wells on each plate were transfected with AnnexinA4 which served as a negative control because it has a role in nervous system function but has no role in neurite initiation or elongation. Two wells on each plate were transfected with a GTP restricted Sar1 mutant that blocks neurite outgrowth and therefore serves as a positive control. After 4 hours the medium was replaced with fresh medium and the cells were left for another 12 hours to express the transfected proteins. After this the medium was replaced with low serum medium (DMEM supplemented with 1% horse serum, 0.5%
foetal calf serum, 1% L-glutamine and 1% penicillin/streptomycin) and the cells were either stimulated with 100 ng/ml of nerve growth factor ( 
Databases
All the data generated in this project are deposited in the following website (http://neurite.embl.de).
Results
Establishment and application of the screen for proteins involved in neurite outgrowth
Rat PC12 cells were chosen as the model cell culture system as they are round shaped in their undifferentiated state but extend long neurites and acquire a sympathetic neuron-like phenotype in response to nerve growth factor (NGF) (Greene and Tischler, 1976) . A PC12 cell line stably transfected with human NGF receptor (PC12 6-15) was chosen, as this line shows a rapid response to NGF stimulation (Hempstead et al., 1992) , and thus suitable for the screening experiments.
We took advantage of a collection of human full-length cDNAs (Wiemann et al., 2001) , the ORFs of which have previously been GFP-tagged at their N and C termini, and have been classified according to their subcellular localisation in Vero cells (Simpson et al., 2000) . From the 1057 available GFP-tagged ORFs only those were considered that were derived from a foetal brain or hypothalamus cDNA library (Wiemann et al., 2001) or S.O.U.R.C.E. database information indicates their expression in the brain. From these, only the GFP-ragged proteins localising to the plasma membrane, cytoskeleton or Golgi complex ( (Simpson et al., 2000) , see web page http://gfp-cdna.embl.de) were chosen for further functional experiments. This resulted in a total of 105 pre-selected proteins of which 35 localise to the cytoskeleton, 31 to the Golgi complex, 22 to the plasma membrane and 17 to both the plasma membrane and Golgi complex (see Supplementary Table 1) .
First, all the 105 pre-selected GFP-tagged proteins were expressed and localised in PC12 cells and the results were compared to their localisation in Vero cells (see Supplementary Table 1) . Only those cells showing low expression levels of the GFP-tagged candidate proteins were analysed. 14 proteins localised to neurite tips after NGF stimulation (see Table 1 and Supplementary Figure 1) . To resolve the moment of their association with neurite tips they were further analysed by time-lapse microscopy. Depending on the time of their association with the neurite tip after NGF stimulation they were classified as "early" or "late" (see summary in Table 1 , selected examples in Figure 4A and 4B and Supplementary Video1 and 2).
Next the 105 candidate proteins were over-expressed in PC12 cells and their effect on neurite outgrowth determined. To characterise parameters such as reproducibility and sensitivity of this approach several control experiments were conducted first. Negative controls such as GFP alone, several major cytoskeletal and membrane traffic components, and proteins with a clear role in neuronal function but not involved in neurite outgrowth all showed little or no effect on neurite outgrowth when over-expressed (Supplementary Table 2 , see also examples in Figure 2 and quantification in Supplementary Figure 2) . Several proteins, known from the literature to influence neurite number or length or to block neurite outgrowth when overexpressed were used as positive controls (Supplementary Table 2 , see also examples
in Figure 2 and quantification in Supplementary Figure 2) . Over-expression of the positive controls influenced neurite outgrowth consistent with their involvement in neurite outgrowth proposed in the literature (see citations in Supplementary Table 2) demonstrating the potential of our experimental approach to identify effectors of neurite outgrowth.
From the 105 pre-selected human GFP-tagged ORFs (see above) 21 were identified as effectors of neurite outgrowth and either influenced neurite length or number or completely blocked neurite outgrowth when over-expressed (Table 2, proteins, although a role in neurite outgrowth had so far not been described for them (Renner et al., 1997; Joberty et al., 1999; Pei et al., 2002; Neubrand et al., 2005) . For 7 of the effector proteins identified (muscarinic receptor m2, synaptopodin, RP/EB family member 3, SH3P12, frizzled homologue 7, Kinesin2 and Kif2C) some role in neurite differentiation has already been described (Baxter and Chiba, 1999; Deller et al., 2000; Nakagawa et al., 2000; Lebre et al., 2001; Ciani and Salinas, 2005; Hirokawa and Takemura, 2005) , but not specifically in the context of neurite initiation and elongation.
Over-expression of 8 proteins was toxic to PC12 cells as judged by their low transfection efficiency (less than 1%) and observed abnormal cell morphology when over-expressed. Three of the GFP-tagged proteins tested (Swissprot ID: P10636, Q8WVP0, Q9P0W8) induced microtubule cytoskeleton abnormalities such as microtubule bundling and were not considered as effectors of neurite outgrowth and were therefore excluded from further analyses. 73 proteins were classified as not interfering with neurite initiation or elongation when over-expressed.
Quantification of gene expression of the positive hits by real time qRT-PCR strengthened our functional results. We quantified the mRNA expression in response to NGF of 15 identified effector proteins. This confirmed their expression in PC12 cells (see Supplementary Table 3 and Supplementary Figure 4) . For the remaining 6 effector proteins we were unable to identify their rat orthologues. The relative expression levels of several genes changed during the course of neurite outgrowth.
Interestingly, the changes in the gene's expression level in some of them could be correlated with the effect of protein over-expression on neurite outgrowth. Three genes that are downregulated during neurite outgrowth (Swissprot ID: Q9BQI0, Q99661, Q15555) encode proteins that blocked neurite outgrowth when overexpressed. Similarly, three genes that are upregulated during neurite outgrowth (SwissprotID: Q9H0V0, Q9UPY8, O14782) encode proteins whose overexpression induced neurite outgrowth or had no effect (Supplementary Table 3 and Supplementary Figure 4) .
Next, for the proteins that blocked neurite outgrowth, we determined when the effect on neurite outgrowth occurred. For this we transfected PC12 cells with the respective GFP-tagged effectors, and monitored neurite outgrowth by time-lapse microscopy for up to 16h after NGF stimulation. This revealed two different phenotypes. One was characterised by the complete absence of neurites at any time after NGF stimulation (Table 3 , also see example in Figure 4C and Supplementary Video3). The second phenotype initially showed no apparent effect on neurite outgrowth after NGF stimulation compared to control transfected cells. However, at later time-points most neurites retracted, resulting in virtually no neurites at 12h after NGF stimulation (Table 3 , also see example in Figure 4D and Supplementary   Video4 ). This potentially reflects on the requirements for those proteins at different stages in neurite outgrowth.
Experimental testing of a possible functional relationship between the identified effector proteins
To further strengthen our screening results we next wanted to establish a possible functional relationship between the identified effector proteins. To this end several of the identified proteins were co-expressed and the effect on the neurite outgrowth was analysed. Borg2, a negative regulator of Cdc42 (Joberty et al., 1999) , was identified in our experiments as blocking neurite outgrowth when over-expressed (see Figure 4C and Supplementary Video3). However, Cdc42 was able to partially overcome this neurite outgrowth block of Borg2 when both proteins were coexpressed ( Figure 5 ). Cells with short neurites could be observed when Cdc42 and Borg2 were co-expressed, while those expressing Borg2 alone showed virtually no neurites ( Figure 5 ). Expression of Cdc42 alone induced numerous filopodia-like extensions around the cell cortex ( Figure 2D ). Since the uncharacterised proteins Q9H0H6, Q4VBK6, Q96PE5 and Q69YW2 induced a similar phenotype as Cdc42 when over-expressed (Table 2 and Supplementary Figure 3) we next asked whether these proteins were also able to overcome the Borg2 phenotype. The co-expression of either Q9H0H6, Q4VBK6 or Q69YW2 with Borg2 was unable to rescue the Borg2 induced phenotype ( Figure 5 ). However, Q96PE5 was able to rescue the Borg2 phenotype and filopodia-like structures around the cell cortex were seen in the majority of cells ( Figure 5 ) similar to when Q96PE5 or Cdc42 were over-expressed on their own ( Figure 2D and 3D) . Similarly, co-expression of Borg2 and EB3, a microtubule (+)-end binding protein (Nakagawa et al., 2000) , whose over-expression on its own induced an increase in the number of neurites per cell (Table 2 and Supplementary Figure 3) , also resulted in a rescue of the Borg2 phenotype ( Figure 5 ).
Taken together, these results show that the novel proteins Q9H0H6, Q4VBK6 and Q69YW2 cannot rescue the Borg2 phenotype, while Q96PE5 and EB3 are able to do so.
Interestingly, in our screening experiments, over-expression of the Frizzled receptor (FZD7), a well known negative regulator of Gsk3β (for a review see (Ciani and Salinas, 2005) ) increased the number of neurites per cell (see Table 2 and Supplementary Figure 3) . Furthermore, it has been shown that Cdc42 is able to inhibit Gsk3 and thereby control microtubule stabilisation and cell polarity in migrating astrocytes (Etienne-Manneville and Hall, 2003) . Gsk3β was also shown to regulate microtubule stabilisation in NGF induced axon growth in DRG neurons (Zhou et al., 2004) . Together this suggests Gsk3β being an important regulator of neurite outgrowth.
Next we wished to investigate the relationship of our identified effector proteins with Gsk3 function in neurite outgrowth. Cells transfected with effector proteins were treated with the specific Gsk3 inhibitor CHIR99021 (Ring et al., 2003) and analysed for neurite outgrowth. The percentage of cells bearing 4 or more neurites increased in a dose dependent manner from 11.5 ± 2% in cells treated with NGF only to 55 ± 2% in cells which were treated with NGF and 20 μM CHIR99021
(Supplementary Figure 5) . Interestingly, neurite outgrowth block induced by Borg2 overexpression could be partially rescued by simultaneously inhibiting Gsk3β with CHIR99021 ( Figure 5 ). Cells with short neurites could be observed, while those expressing Borg2 in the absence of the inhibitor showed virtually no neurites ( Figure   5 , see also Supplementary Video3). In contrast, Gsk3β inhibition was unable to rescue the neurite outgrowth block induced by overexpression of the microtubule binding proteins EB2 and KAP3 (kinesin2 complex component) ( Figure 5B ) or the novel proteins Q9Y4P9 and Q9H0Q7 (not shown). A summary of these experiments addressing a possible functional relationship between the effector proteins identified here is shown in Figure 5C .
Discussion
Here we describe the establishment and application of a microscopy-based approach to identify new proteins involved in neurite initiation and elongation in response to NGF in PC12 cells. The candidate proteins used for the experiments were pre-selected according to their tissue specific expression and sub-cellular localisation in Vero cells (Simpson et al., 2000) . Based on these criteria we chose from 1057 available proteins 105 that we finally tested in our experiments for a possible involvement in neurite outgrowth. This revealed 21 effector proteins with a potential role as regulators of neurite initiation or elongation. One reason for this high success rate is likely to be the pre-selection of the candidate proteins based on their expression in nervous tissue and sub-cellular localisation.
We also performed co-transfection experiments, which allowed us to determine the action of new, previously uncharacterised human effector proteins with respect to Gsk3β and Cdc42-Borg2 function. These co-transfection experiments further support our screening data and provide a first glimpse on how these newly identified proteins might interact with established regulators of neurite outgrowth, such as Gsk3β and Cdc42. Further experiments on these effector proteins will be necessary in order to determine if and how they may be part of a network regulating neurite outgrowth. The experimental data presented here should provide an excellent basis for such detailed studies with the aim to obtain a more comprehensive view on the molecular networks underlying neurite outgrowth.
Although it cannot be formally ruled out, several lines of evidence exist to assure that our over-expression approach did not yield unspecific results. First, proteins with an established role in neuronal differentiation and function but not involved in neurite initiation or elongation showed no apparent effect on neurite outgrowth in our experiments. Second, 14 proteins out of the 105 tested were identified as localising to neurite tips but 11 of them had no effect on neurite number or length when over-expressed. Third, a number of proteins we identified here as affecting neurite outgrowth are homologues or orthologues of well characterised proteins already implicated in some aspects of neurite outgrowth in the literature. Table 1 ). By extending this approach to a larger number of neurite tip localised proteins it should be possible to generate a temporal map of protein association with neurite tips which could serve as a basis for network construction and more detailed functional studies.
By using high throughput and high content microscopy technology in fixed (Liebel et al., 2003) and living (Neumann et al., 2006) cells together with fully automated image analysis to quantify neurite outgrowth (Ramm et al., 2003) it should be possible to scale-up our approach here from low to high throughput and might thus become the basis for future large scale neuronal-based proteomic studies.
It is interesting to note that there appears to be a strong correlation between the sub-cellular localisation of the effector proteins and the phenotype generated. Six out of seven proteins that induced an increase in the number of neurites per cell in our experiments localise to the plasma membrane. This finding is consistent with the view that the neurite outgrowth begins when external signals activate specific factors on the plasma membrane which in turn triggers the formation of a neurite initiation site that should be distinct from the rest of the plasma membrane at the molecular level.
Similarly, nine out of eleven proteins identified as blockers of neurite outgrowth localised either to the actin or microtubule cytoskeleton. This is in full agreement with numerous earlier studies, establishing a major role of the cytoskeleton in the control of neurite outgrowth (for reviews see (Gallo and Letourneau, 2000; da Silva and Dotti, 2002) ). Finally, effector proteins which affected neurite length upon overexpression are all localised to the Golgi or plasma membrane and are involved in membrane traffic regulation. This is consistent with the view that the delivery of new membrane to growing neurites is an important factor for their growth (for reviews see (Futerman and Banker, 1996; Valtorta and Leoni, 1999) ).
Three proteins identified in our screen are of additional interest because they are potentially involved in human neurological disorders. Swissprot IDs: Q96PE5 (Nobile et al., 2002) and Q9BQJ4 (Christophe-Hobertus et al., 2001 ) have a potential role in temporal lobe epilepsy and hereditary X-linked mental retardation, respectively. However, in both cases previous research reported no mutations in these genes in families carrying the disease (Nobile et al., 2002; Christophe-Hobertus et al., 2004) and thus both genes are presently considered as "unlikely" to be involved in the respective disorders. However this earlier work did not investigate the 5'-regulatory regions of the respective genes and therefore mutations occurring in the promoter region of the genes cannot be excluded as the cause of disease. Consistent with our data, it is therefore possible that in fact deregulation of protein expression and not loss
of function is what is causing the neurological disorders related to these two genes.
Therefore, based on our data here, the involvement of Q96PE5 and Q9BQJ4 in temporal lobe epilepsy and X-linked mental retardation could be possible, and should thus be re-evaluated with respect to their regulation and expression. The third disease linked protein identified is SH3P12. It has been shown to interact with Ataxin-7 and huntingtin, both of which are key players in the neurodegenerative diseases Spinocerebellar ataxia and Huntington disease, respectively (Lebre et al., 2001 ).
Since, overexpression of SH3P12 blocked neurite outgrowth in PC12 cells, nervous system dysfunction may be related to changes in SH3P12 expression.
Extending this approach to a larger number of candidate proteins and complementing it with RNAi experiments and more detailed functional experiments, such as protein-protein interaction studies will ultimately lead a more comprehensive understanding of neurite outgrowth at the molecular level. Secreted phosphoprotein 1, SPP-1 (Q96IZ1) * The 14 proteins localising to neurite tips after NGF stimulation were analysed in more detail by time-lapse microscopy and classified as "early", when association occurred before any neurites were visible or coincidental with the beginning of neurite outgrowth. They were classified as "late" when association was first observed after neurites had already clearly formed.
Tables
SwissPROT IDs are given in parentheses. Figure 2 , Figure 3 , Supplementary Figure 3 and quantification of these phenotypes is shown in Supplementary Figure 2 . 
